Oncoinvent ASA (KLDVK) — Cash Flow Quality Index

Latest as of December 2023: -0.56x

Oncoinvent ASA (KLDVK) has a Cash Flow Quality Index of -0.56x as of December 2023. Operating cash flow of Nkr-40.23 Million is below net income of Nkr72.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Oncoinvent ASA balance sheet assets for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.56x
Operating CF / Net Income

Operating Cash Flow

Nkr-40.23 Million
NOK

Net Income

Nkr72.41 Million
NOK

Data as of

Dec 2023
Most recent filing

Oncoinvent ASA Cash Flow Quality Index (2021–2023)

Historical Cash Flow Quality Index for Oncoinvent ASA across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Oncoinvent ASA to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Oncoinvent ASA (2021–2023)

Year-by-year earnings quality comparison for Oncoinvent ASA. For live market cap and the full company financial profile, see Oncoinvent ASA market capitalisation.

Year Quality Index Operating CF (NOK) Net Income YoY Change
2023 -0.56x Nkr-40.23 Million Nkr72.41 Million ▼ -949.1%
2021 0.07x Nkr130.66K Nkr2.00 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.